{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:44:36Z","timestamp":1770504276596,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":4911,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.jpain.2009.07.017","type":"journal-article","created":{"date-parts":[[2009,11,28]],"date-time":"2009-11-28T04:39:30Z","timestamp":1259383170000},"page":"303-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["ALO-01 (Morphine Sulfate and Naltrexone Hydrochloride) Extended-Release Capsules in the Treatment of Chronic Pain of Osteoarthritis of the Hip or Knee: Pharmacokinetics, Efficacy, and Safety"],"prefix":"10.1016","volume":"11","author":[{"given":"Nathaniel","family":"Katz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franklin","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Stauffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2009.07.017_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/art.1780340502","article-title":"The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip","volume":"34","author":"Altman","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpain.2009.07.017_bib2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","article-title":"Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee: Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association","volume":"29","author":"Altman","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpain.2009.07.017_bib3","first-page":"524","article-title":"Relative bioavailability of controlled-release morphine sulfate during naltrexone blockade","volume":"33","author":"Bashaw","year":"1995","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.jpain.2009.07.017_bib4","first-page":"1833","article-title":"Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee","volume":"15","author":"Bellamy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpain.2009.07.017_bib5","first-page":"129","article-title":"Pain assessment: Global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singapore"},{"issue":"Suppl 1","key":"10.1016\/j.jpain.2009.07.017_bib6","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.drugalcdep.2005.11.027","article-title":"Ephemeral profiles of prescription drug and formulation tampering: Evolving pseudoscience on the Internet","volume":"83","author":"Cone","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpain.2009.07.017_bib7","first-page":"273","article-title":"Review of naltrexone, a long-acting opiate antagonist","volume":"3","author":"Crabtree","year":"1984","journal-title":"Clin Pharm"},{"key":"10.1016\/j.jpain.2009.07.017_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/00003088-199835030-00002","article-title":"Sustained relief of chronic pain: Pharmacokinetics of sustained release morphine","author":"Gourlay","year":"1998","journal-title":"Clin Pharmacokinet [abstract 235]"},{"key":"10.1016\/j.jpain.2009.07.017_bib9","unstructured":"Johnson FK, Ciric S, Boudriau S, Swearingen D, Stauffer J: Effect of food and sprinkling of pellets on applesauce on the pharmacokinetics of ALO-01 [abstract 99]. Presented at: 2008 American Association of Pharmaceutical Scientists Annual Meeting and Exposition; Atlanta, GA"},{"issue":"4 Suppl 2","key":"10.1016\/j.jpain.2009.07.017_bib10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpain.2008.01.156","article-title":"Evaluation of abuse potential of ALO-01, and extended release morphine sulfate plus sequestered naltrexone formulation, among recreational opioid users","volume":"9","author":"Jones","year":"2008","journal-title":"J Pain [abstract 235]"},{"key":"10.1016\/j.jpain.2009.07.017_bib11","unstructured":"KADIAN Capsules [Package Insert]. Morristown, NJ, Actavis US; 2008"},{"key":"10.1016\/j.jpain.2009.07.017_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/j.1552-4604.1995.tb04094.x","article-title":"A bioequivalence study of oral controlled-release morphine using naltrexone blockade","volume":"35","author":"Kaiko","year":"1995","journal-title":"J Clin Pharmacol"},{"issue":"Suppl 2","key":"10.1016\/j.jpain.2009.07.017_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jpain.2008.01.181","article-title":"Efficacy and safety evaluation of an extended-release morphine sulfate formulation with sequestered naltrexone for the treatment of osteoarthritis","volume":"9","author":"Katz","year":"2008","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2009.07.017_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.ajp.0000210953.86255.8f","article-title":"Foundations of opioid risk management","volume":"23","author":"Katz","year":"2007","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpain.2009.07.017_bib15","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/AJP.0b013e318125c5e8","article-title":"Challenges in the development of prescription opioid abuse-deterrent formulations","volume":"23","author":"Katz","year":"2007","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpain.2009.07.017_bib16","first-page":"1965","article-title":"Scientists probe ways to curb opioid abuse without hindering pain treatment","volume":"297","author":"Kuehn","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2009.07.017_bib17","unstructured":"Lipman AG, Jackson KC II: Opioid pharmacotherapy, in Warfield CA, Bajwa ZH (eds): Principles and Practices of Pain Medicine. New York, NY, 2004, pp 583-600"},{"key":"10.1016\/j.jpain.2009.07.017_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00045391-200105000-00006","article-title":"Long-acting opioids for chronic pain: Pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia","volume":"8","author":"McCarberg","year":"2001","journal-title":"Am J Ther"},{"key":"10.1016\/j.jpain.2009.07.017_bib19","unstructured":"National Institute for Health and Clinical Excellence: Naltrexone for the Management of Opioid Dependence. London, UK, National Institute for Health and Clinical Excellence, 2007, pp 1-28"},{"key":"10.1016\/j.jpain.2009.07.017_bib20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1176\/ajp.131.6.646","article-title":"Studies of EN-1639A (naltrexone): A new narcotic antagonist","volume":"131","author":"Resnick","year":"1974","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpain.2009.07.017_bib21","unstructured":"ReVia naltrexone hydrochloride, product monograph. Pomona, NY, Duramed Pharmaceuticals, Inc, 2003"},{"key":"10.1016\/j.jpain.2009.07.017_bib22","series-title":"ReVia [package insert]","year":"2007"},{"key":"10.1016\/j.jpain.2009.07.017_bib23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1517\/17425247.3.4.489","article-title":"Extended-release opioids for the management of chronic non-malignant pain","volume":"3","author":"Sloan","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.jpain.2009.07.017_bib24","series-title":"Results from the 2007 National Survey on Drug Use and Health: National Findings","author":"Substance Abuse and Mental Health Services Administration","year":"2008"},{"key":"10.1016\/j.jpain.2009.07.017_bib25","unstructured":"US Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research (CDER): Guidance for Industry: Statistical Approaches to Establishing Bioequivalence. 2001"},{"key":"10.1016\/j.jpain.2009.07.017_bib26","unstructured":"US Department of Health and Human Services, Food\u00a0and Drug Administration Center for Drug Evaluation and\u00a0Research (CDER): Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations; Revision 1. 2003"},{"key":"10.1016\/j.jpain.2009.07.017_bib27","series-title":"Naltrexone Pharmacochemistry and Sustained Release Preparations: Research Monograph","first-page":"147","article-title":"The clinical pharmacology of naltrexone: Pharmacology and pharmacodynamics","author":"Verebey","year":"1981"},{"key":"10.1016\/j.jpain.2009.07.017_bib28","first-page":"61","article-title":"Use and abuse of opioid analgesics: Potential methods to prevent and deter non-medical consumption of prescription opioids","volume":"5","author":"Woolf","year":"2004","journal-title":"Curr Opin Invest Drugs"},{"issue":"Suppl\u00a01","key":"10.1016\/j.jpain.2009.07.017_bib29","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.drugalcdep.2005.12.012","article-title":"Risk identification, risk assessment, and risk management of\u00a0abusable drug formulations","volume":"83","author":"Wright","year":"2006","journal-title":"Drug Alcohol Depend"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590009006968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590009006968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:48:32Z","timestamp":1761508112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590009006968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1526590009006968"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2009.07.017","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ALO-01 (Morphine Sulfate and Naltrexone Hydrochloride) Extended-Release Capsules in the Treatment of Chronic Pain of Osteoarthritis of the Hip or Knee: Pharmacokinetics, Efficacy, and Safety","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2009.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Pain Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}